{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:37:36Z","timestamp":1790861856727,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11011-010-9230-x","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T04:32:53Z","timestamp":1294720373000},"page":"9-19","source":"Crossref","is-referenced-by-count":18,"title":["Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice"],"prefix":"10.1007","volume":"26","author":[{"given":"Douglas M.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"DiRosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadra","family":"Gulaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smruti","family":"Killedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Oosterhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toin H.","family":"van Kuppevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"9230_CR1","first-page":"36","volume":"11","author":"MD Abramoff","year":"2004","unstructured":"Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with image. J Biophotonics Int 11:36\u201342","journal-title":"J Biophotonics Int"},{"key":"9230_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","volume":"121","author":"M Beck","year":"2007","unstructured":"Beck M (2007) New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 121:1\u201322","journal-title":"Hum Genet"},{"key":"9230_CR3","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","volume":"27","author":"CN Cearley","year":"2007","unstructured":"Cearley CN, Wolfe JH (2007) A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J Neurosci 27:9928\u20139940","journal-title":"J Neurosci"},{"key":"9230_CR4","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","volume":"24","author":"A Cressant","year":"2004","unstructured":"Cressant A, Desmaris N, Verot L, Brejot T, Froissart R, Vanier MT, Maire I, Heard JM (2004) Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J Neurosci 24:10229\u201310239","journal-title":"J Neurosci"},{"key":"9230_CR5","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1074\/jbc.M104852200","volume":"277","author":"MA Dennissen","year":"2002","unstructured":"Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH (2002) Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem 277:10982\u201310986","journal-title":"J Biol Chem"},{"key":"9230_CR6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.20150","volume":"56","author":"N Desmaris","year":"2004","unstructured":"Desmaris N, Verot L, Puech JP, Caillaud C, Vanier MT, Heard JM (2004) Prevention of neuropathology in the mouse model of Hurler syndrome. Ann Neurol 56:68\u201376","journal-title":"Ann Neurol"},{"key":"9230_CR7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jnr.21912","volume":"87","author":"J DiRosario","year":"2009","unstructured":"DiRosario J, Divers E, Wang C, Etter J, Charrier A, Jukkola P, Auer H, Best V, Newsom DL, McCarty DM, Fu H (2009) Innate and adaptive immune activation in the brain of MPS IIIB mouse model. J Neurosci Res 87:978\u2013990","journal-title":"J Neurosci Res"},{"key":"9230_CR8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ejhg.2009.144","volume":"18","author":"D Dziedzic","year":"2010","unstructured":"Dziedzic D, Wegrzyn G, Jakobkiewicz-Banecka J (2010) Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease. Eur J Hum Genet 18:200\u2013205","journal-title":"Eur J Hum Genet"},{"key":"9230_CR9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","volume":"71","author":"JD Esko","year":"2002","unstructured":"Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435\u2013471","journal-title":"Annu Rev Biochem"},{"key":"9230_CR10","first-page":"567","volume-title":"Essentials of glycobiology","author":"H Freeze","year":"2008","unstructured":"Freeze H (2008) Genetic disorders of glycan degradation. In: Varki A, Cummings R, Esko J, Freeze H, Stanley P, Bertozzi C, Hart G, Etzler M (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory, New York, pp 567\u2013583","edition":"2"},{"key":"9230_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/mthe.2001.0514","volume":"5","author":"H Fu","year":"2002","unstructured":"Fu H, Samulski RJ, McCown TJ, Picornell YJ, Fletcher D, Muenzer J (2002) Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol Ther 5:42\u201349","journal-title":"Mol Ther"},{"key":"9230_CR12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.gt.3302961","volume":"14","author":"H Fu","year":"2007","unstructured":"Fu H, Kang L, Jennings JS, Moy SS, Perez A, Dirosario J, McCarty DM, Muenzer J (2007) Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Ther 14:1065\u20131077","journal-title":"Gene Ther"},{"key":"9230_CR13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jgm.1480","volume":"12","author":"H Fu","year":"2010","unstructured":"Fu H, DiRosario J, Kang L, Muenzer J, McCarty DM (2010) Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery. J Gene Med 12:624\u2013633","journal-title":"J Gene Med"},{"key":"9230_CR14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.10373","volume":"52","author":"GG Heuer","year":"2002","unstructured":"Heuer GG, Passini MA, Jiang K, Parente MK, Lee VM, Trojanowski JQ, Wolfe JH (2002) Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible. Ann Neurol 52:762\u2013770","journal-title":"Ann Neurol"},{"key":"9230_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1423-0127-16-26","volume":"16","author":"J Jakobkiewicz-Banecka","year":"2009","unstructured":"Jakobkiewicz-Banecka J, Piotrowska E, Narajczyk M, Baranska S, Wegrzyn G (2009) Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway. J Biomed Sci 16:26","journal-title":"J Biomed Sci"},{"key":"9230_CR16","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1523\/JNEUROSCI.20-11-04099.2000","volume":"20","author":"GJ Jenniskens","year":"2000","unstructured":"Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH (2000) Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci 20:4099\u20134111","journal-title":"J Neurosci"},{"key":"9230_CR17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/dvdy.10138","volume":"225","author":"GJ Jenniskens","year":"2002","unstructured":"Jenniskens GJ, Hafmans T, Veerkamp JH, van Kuppevelt TH (2002) Spatiotemporal distribution of heparan sulfate epitopes during myogenesis and synaptogenesis: a study in developing mouse intercostal muscle. Dev Dyn 225:70\u201379","journal-title":"Dev Dyn"},{"key":"9230_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ejhg.2009.143","volume":"18","author":"X Kaidonis","year":"2010","unstructured":"Kaidonis X, Liaw WC, Roberts AD, Ly M, Anson D, Byers S (2010) Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses. Eur J Hum Genet 18:194\u2013199","journal-title":"Eur J Hum Genet"},{"key":"9230_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-7-39","volume":"7","author":"S Killedar","year":"2010","unstructured":"Killedar S, Dirosario J, Divers E, Popovich PG, McCarty DM, Fu H (2010) Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J Neuroinflammation 7:39","journal-title":"J Neuroinflammation"},{"key":"9230_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.mt.6300012","volume":"15","author":"T Kurai","year":"2007","unstructured":"Kurai T, Hisayasu S, Kitagawa R, Migita M, Suzuki H, Hirai Y, Shimada T (2007) AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy. Mol Ther 15:38\u201343","journal-title":"Mol Ther"},{"key":"9230_CR21","doi-asserted-by":"crossref","first-page":"21032","DOI":"10.1074\/jbc.M702073200","volume":"282","author":"S Kurup","year":"2007","unstructured":"Kurup S, Wijnhoven TJ, Jenniskens GJ, Kimata K, Habuchi H, Li JP, Lindahl U, van Kuppevelt TH, Spillmann D (2007) Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. J Biol Chem 282:21032\u201321042","journal-title":"J Biol Chem"},{"key":"9230_CR22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2004050413","volume":"16","author":"JF Lensen","year":"2005","unstructured":"Lensen JF, Rops AL, Wijnhoven TJ, Hafmans T, Feitz WF, Oosterwijk E, Banas B, Bindels RJ, van den Heuvel LP, van der Vlag J, Berden JH, van Kuppevelt TH (2005) Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies. J Am Soc Nephrol 16:1279\u20131288","journal-title":"J Am Soc Nephrol"},{"key":"9230_CR23","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"HH Li","year":"1999","unstructured":"Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S, Fanselow MS, Suzuki K, Vanier MT, Neufeld EF (1999) Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 96:14505\u201314510","journal-title":"Proc Natl Acad Sci USA"},{"key":"9230_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10278","volume":"69","author":"HH Li","year":"2002","unstructured":"Li HH, Zhao HZ, Neufeld EF, Cai Y, Gomez-Pinilla F (2002) Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res 69:30\u201338","journal-title":"J Neurosci Res"},{"key":"9230_CR25","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","volume":"25","author":"G Liu","year":"2005","unstructured":"Liu G, Martins I, Wemmie JA, Chiorini JA, Davidson BL (2005) Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J Neurosci 25:9321\u20139327","journal-title":"J Neurosci"},{"key":"9230_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"9230_CR27","doi-asserted-by":"crossref","unstructured":"Malinowska M, Wilkinson FL, Bennett W, Langford-Smith KJ, O\u2019Leary HA, Jakobkiewicz-Banecka J, Wynn R, Wraith JE, Wegrzyn G, Bigger BW (2009) Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab","DOI":"10.1016\/j.ymgme.2009.06.013"},{"key":"9230_CR28","doi-asserted-by":"crossref","unstructured":"McCarty DM, Dirosario J, Gulaid K, Muenzer J, Fu H (2009) Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice. Gene Ther","DOI":"10.1038\/gt.2009.85"},{"key":"9230_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","volume":"480","author":"R McGlynn","year":"2004","unstructured":"McGlynn R, Dobrenis K, Walkley SU (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480:415\u2013426","journal-title":"J Comp Neurol"},{"key":"9230_CR30","first-page":"3421","volume-title":"The metabolic & molecular basis of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 3421\u20133452","edition":"8"},{"key":"9230_CR31","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100:1902\u20131907","journal-title":"Proc Natl Acad Sci USA"},{"key":"9230_CR32","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1073\/pnas.0903223106","volume":"106","author":"K Ohmi","year":"2009","unstructured":"Ohmi K, Kudo LC, Ryazantsev S, Zhao HZ, Karsten SL, Neufeld EF (2009) Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci USA 106:8332\u20138337","journal-title":"Proc Natl Acad Sci USA"},{"key":"9230_CR33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1651-2227.2008.01153.x","volume":"98","author":"E Piotrowska","year":"2009","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Tylki-Szymanska A, Czartoryska B, Wegrzyn A, Wegrzyn G (2009) Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatr 98:743\u2013749","journal-title":"Acta Paediatr"},{"key":"9230_CR34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/01.pdr.0000233037.00707.da","volume":"60","author":"AL Roberts","year":"2006","unstructured":"Roberts AL, Thomas BJ, Wilkinson AS, Fletcher JM, Byers S (2006) Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA. Pediatr Res 60:309\u2013314","journal-title":"Pediatr Res"},{"key":"9230_CR35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2007.06.016","volume":"92","author":"AL Roberts","year":"2007","unstructured":"Roberts AL, Rees MH, Klebe S, Fletcher JM, Byers S (2007) Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA. Mol Genet Metab 92:115\u2013121","journal-title":"Mol Genet Metab"},{"key":"9230_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.ki.5002573","volume":"73","author":"AL Rops","year":"2008","unstructured":"Rops AL, van den Hoven MJ, Baselmans MM, Lensen JF, Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, Berden JH, van der Vlag J (2008) Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. Kidney Int 73:52\u201362","journal-title":"Kidney Int"},{"key":"9230_CR37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2006.11.006","volume":"90","author":"S Ryazantsev","year":"2007","unstructured":"Ryazantsev S, Yu WH, Zhao HZ, Neufeld EF, Ohmi K (2007) Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 90:393\u2013401","journal-title":"Mol Genet Metab"},{"key":"9230_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1651-2227.2008.00660.x","volume":"97","author":"MS Sands","year":"2008","unstructured":"Sands MS, Haskins ME (2008) CNS-directed gene therapy for lysosomal storage diseases. Acta Paediatr Suppl 97:22\u201327","journal-title":"Acta Paediatr Suppl"},{"key":"9230_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/10430340050015707","volume":"11","author":"TJ Sferra","year":"2000","unstructured":"Sferra TJ, Qu G, McNeely D, Rennard R, Clark KR, Lo WD, Johnson PR (2000) Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum Gene Ther 11:507\u2013519","journal-title":"Hum Gene Ther"},{"key":"9230_CR40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1165\/rcmb.2003-0198OC","volume":"30","author":"NC Smits","year":"2004","unstructured":"Smits NC, Robbesom AA, Versteeg EM, van de Westerlo EM, Dekhuijzen PN, van Kuppevelt TH (2004) Heterogeneity of heparan sulfates in human lung. Am J Respir Cell Mol Biol 30:166\u2013173","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9230_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0076-6879(06)16005-X","volume":"416","author":"NC Smits","year":"2006","unstructured":"Smits NC, Lensen JF, Wijnhoven TJ, Ten Dam GB, Jenniskens GJ, van Kuppevelt TH (2006) Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol 416:61\u201387","journal-title":"Methods Enzymol"},{"key":"9230_CR42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/002215540305100604","volume":"51","author":"GB Dam ten","year":"2003","unstructured":"ten Dam GB, Hafmans T, Veerkamp JH, van Kuppevelt TH (2003) Differential expression of heparan sulfate domains in rat spleen. J Histochem Cytochem 51:727\u2013739","journal-title":"J Histochem Cytochem"},{"key":"9230_CR43","doi-asserted-by":"crossref","first-page":"38346","DOI":"10.1074\/jbc.M404166200","volume":"279","author":"GB Dam ten","year":"2004","unstructured":"ten Dam GB, van de Westerlo EM, Smetsers TF, Willemse M, van Muijen GN, Merry CL, Gallagher JT, Kim YS, van Kuppevelt TH (2004) Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n. J Biol Chem 279:38346\u201338352","journal-title":"J Biol Chem"},{"key":"9230_CR44","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1074\/jbc.M506357200","volume":"281","author":"GB Dam Ten","year":"2006","unstructured":"Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, Spillmann D, van Kuppevelt TH (2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem 281:4654\u20134662","journal-title":"J Biol Chem"},{"key":"9230_CR45","first-page":"567","volume-title":"Techniques in diagnostic human biochemical genetics\u2014a laboratory manual","author":"JN Thompson","year":"1991","unstructured":"Thompson JN, Nowakowski RW (1991) Enzymatic diagnosis of selected mucopolysaccharidoses: Hunter, Morquio type A, and Sanfilippo types A, B, C, and D, and procedures for measurement of 35SO4-glycosaminoglycans. In: Hommes FA (ed) Techniques in diagnostic human biochemical genetics\u2014a laboratory manual. Wiley-Liss, New York, pp 567\u2013586"},{"key":"9230_CR46","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/mt.2009.142","volume":"17","author":"A Ulusoy","year":"2009","unstructured":"Ulusoy A, Sahin G, Bjorklund T, Aebischer P, Kirik D (2009) Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons. Mol Ther 17:1574\u20131584","journal-title":"Mol Ther"},{"key":"9230_CR47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/gad.1399806","volume":"20","author":"MA Valencia-Sanchez","year":"2006","unstructured":"Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515\u2013524","journal-title":"Genes Dev"},{"key":"9230_CR48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1113\/jphysiol.2005.090985","volume":"568","author":"V Valiunas","year":"2005","unstructured":"Valiunas V, Polosina YY, Miller H, Potapova IA, Valiuniene L, Doronin S, Mathias RT, Robinson RB, Rosen MR, Cohen IS, Brink PR (2005) Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 568:459\u2013468","journal-title":"J Physiol"},{"key":"9230_CR49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/abio.1994.1425","volume":"221","author":"CH Lest van de","year":"1994","unstructured":"van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH (1994) Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem 221:356\u2013361","journal-title":"Anal Biochem"},{"key":"9230_CR50","doi-asserted-by":"crossref","first-page":"12960","DOI":"10.1074\/jbc.273.21.12960","volume":"273","author":"TH Kuppevelt van","year":"1998","unstructured":"van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273:12960\u201312966","journal-title":"J Biol Chem"},{"key":"9230_CR51","first-page":"519","volume":"171","author":"TH Kuppevelt van","year":"2001","unstructured":"van Kuppevelt TH, Jenniskens GJ, Veerkamp JH, ten Dam GB, Dennissen MA (2001) Phage display technology to obtain antiheparan sulfate antibodies. Methods Mol Biol 171:519\u2013534","journal-title":"Methods Mol Biol"},{"key":"9230_CR52","first-page":"37","volume-title":"Essentials of glycobiology","author":"A Varki","year":"2008","unstructured":"Varki A, Esko J, Colly K (2008) Cellular organization of glycosylation. In: Varki A, Cummings R, Esko J, Freeze HS, Stanley P, Bertozzi C, Hart C, Etzler M (eds) Essentials of glycobiology, 2nd edn. CSH, New York, pp 37\u201346","edition":"2"},{"key":"9230_CR53","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jnr.21134","volume":"85","author":"GR Villani","year":"2007","unstructured":"Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez YRE, Di Natale P (2007) Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 85:612\u2013622","journal-title":"J Neurosci Res"},{"key":"9230_CR54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2007.00202.x","volume":"96","author":"SU Walkley","year":"2007","unstructured":"Walkley SU (2007) Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr Suppl 96:26\u201332","journal-title":"Acta Paediatr Suppl"},{"key":"9230_CR55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10719-007-9070-z","volume":"25","author":"TJ Wijnhoven","year":"2008","unstructured":"Wijnhoven TJ, van de Westerlo EM, Smits NC, Lensen JF, Rops AL, van der Vlag J, Berden JH, van den Heuvel LP, van Kuppevelt TH (2008) Characterization of anticoagulant heparinoids by immunoprofiling. Glycoconj J 25:177\u2013185","journal-title":"Glycoconj J"},{"key":"9230_CR56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.1189","volume":"18","author":"G Yogalingam","year":"2001","unstructured":"Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat 18:264\u2013281","journal-title":"Hum Mutat"},{"key":"9230_CR57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ymgme.2004.06.004","volume":"82","author":"Y Zheng","year":"2004","unstructured":"Zheng Y, Ryazantsev S, Ohmi K, Zhao HZ, Rozengurt N, Kohn DB, Neufeld EF (2004) Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Mol Genet Metab 82:286\u2013295","journal-title":"Mol Genet Metab"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-010-9230-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T19:08:10Z","timestamp":1559934490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-010-9230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9230"],"URL":"https:\/\/doi.org\/10.1007\/s11011-010-9230-x","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,12]]}}}